Patent · US Active

Chemical compounds, compositions and methods for kinase modulation

US9181221B2 · kind B2 · utility

62Cited by

175References

18Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Pingda Ren · San Diego, US
Yi Liu · San Diego, US
Liansheng Li · San Diego, US
Katrina Chan · Fremont, US
Alfredo C. Castro · Woburn, US
Catherine A. Evans · Somerville, US

Key dates

Filing date	Nov 20, 2013
Grant date	Nov 10, 2015
Priority date	—
Expiry date	Nov 20, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted isoquinolinone compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.